Real-time enrollment status for this chemotherapy-induced peripheral neuropathy clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 2:25 PM UTC
| NCT Number | NCT07765446 |
| Recruiting Status | Recruiting |
| Condition | Chemotherapy-induced Peripheral Neuropathy |
| Phase | PHASE2 |
| Target Enrollment | 18 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Sironax USA, Inc. |
| Last Updated on CT.gov | September 1, 2026 (Yesterday) |
As of September 2, 2026: Clinical trial NCT07765446 is currently recruiting participants. This phase2 study for chemotherapy-induced peripheral neuropathy is actively seeking new participants at 2 locations across the United States. The study is sponsored by Sironax USA, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07765446 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07765446 was last updated Yesterday (September 1, 2026). HelloStudys verifies this status automatically.